Table 1 Patient characteristics and clinical details
Fentanyl (n = 34) | Remifentanil (n = 35) | |
|---|---|---|
Age (yr) | 52.0 (39.8–66.3) | 52.0 (42.0–64.0) |
Sex | ||
M | 23 (68) | 24 (69) |
F | 11 (32) | 11 (31) |
Height (m) | 1.66 (1.61–1.70) | 1.65 (1.58–1.76) |
Weight (kg) | 63.1 (52.7–70.6) | 67.0 (53.1–75.2) |
ASA physical status | ||
I | 13 (38) | 10 (29) |
II | 21 (62) | 25 (71) |
Diagnosis | ||
renal carcinoma | 23 (68) | 27 (77) |
ureteropelvic junction stenosis | 11 (32) | 8 (23) |
Duration of anesthesia (min) | 300 (267–344) | 310 (260–336) |
Duration of surgery (min) | 217 (183–263) | 230 (188–272) |
Duration of insufflation (min) | 168 (139–209) | 166 (130–205) |
Intravenous infusion (ml) | 2500 ± 598 | 2481 ± 730 |
Blood loss (ml) | 0 (0–75) | 20 (0–50) |
Total dose of fentanyl during surgery (μg) | 660 (494–811) | 400 (350–500) |
Length of hospital stay (day) | 12 (10–13) | 12 (11–13) |
Smoking history | 12 (35) | 16 (46) |
Kinetosis history | 4 (12) | 5 (14) |
PONV history | 1 (3) | 1 (3) |